Glucosamine Fermentation via Engineered Microbial Pathways
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing glucosamine and N-acetylglucosamine are costly, yield low quantities, and face challenges such as shellfish allergy concerns and limited raw material availability, with existing microbial fermentation methods not meeting market demand effectively.
Innovation Solution
A method involving genetically modified microorganisms with specific genetic modifications to increase the activity of enzymes like glucosamine-6-phosphate acetyltransferase and glucosamine-6-phosphate synthase, allowing for the fermentation-based production of glucosamine and N-acetylglucosamine with higher yields and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If acid hydrolysis of chitin is used to produce glucosamine, then glucosamine can be obtained from natural sources, but the process is low yield, energy intensive, and chemically intensive
Solution Approach 1:
The patent replaces the chemical hydrolysis process with a biological fermentation process using genetically modified microorganisms. Instead of using concentrated hydrochloric acid at high temperature for depolymerization and deacetylation, the invention uses engineered bacteria to biosynthesize glucosamine through metabolic pathways, substituting chemical mechanisms with biological ones to achieve higher efficiency and lower energy consumption
Solution Approach 2:
The patent modifies the metabolic parameters of microorganisms through genetic engineering to optimize glucosamine production. By overexpressing key enzymes (glucosamine-6-phosphate synthase, phosphoglucoisomerase) and blocking competing pathways (glucosamine-6-phosphate deaminase), the invention changes the biochemical parameters of the production system to achieve high-yield glucosamine synthesis from simple carbon sources
2Quantity of substance
If chitin from shellfish refuse is processed to obtain glucosamine, then raw material is inexpensive, but large volumes are required and the process is low yield
Solution Approach 1:
The patent extracts the glucosamine production capability from the complex chitin processing chain and embeds it in genetically modified microorganisms. Instead of processing large volumes of chitin-containing refuse through multiple purification and hydrolysis steps, the invention directly synthesizes glucosamine in vivo using simple carbon sources like glucose, eliminating the need for chitin extraction and processing
Solution Approach 2:
The genetically modified microorganisms serve themselves by converting simple carbon sources into glucosamine through their own metabolic pathways. The engineered bacteria autonomously perform the synthesis without requiring external chitin substrate, effectively making the production system self-sufficient and independent of shellfish refuse volumes
3Ease of manufacture
If concentrated hydrochloric acid is used for depolymerization and deacetylation, then chitin can be converted to glucosamine, but the process requires high temperature, long times, and low yields
Solution Approach 1:
The patent substitutes the high-temperature acid hydrolysis process with a mild biological fermentation process. Instead of using concentrated HCl at elevated temperatures for extended periods, the invention employs genetically modified microorganisms that biosynthesize glucosamine under mild physiological conditions, dramatically reducing processing time and eliminating the need for harsh chemical treatments
Solution Approach 2:
The patent changes the operational parameters from extreme chemical conditions (high temperature, concentrated acid, long reaction times) to mild biological conditions (physiological temperature, neutral pH, optimized fermentation time). By engineering the microbial metabolic pathways, the invention achieves efficient glucosamine production under gentle conditions that save time and energy
4Ease of manufacture
If glucosamine is produced as free base, then the product form is simple, but it is very unstable and subject to degradation
Solution Approach 1:
The patent replaces the chemical salt formation process with a biological production approach where glucosamine is synthesized and immediately available in stable forms. The genetically modified microorganisms produce glucosamine that can be directly isolated or converted to stable salts without requiring harsh chemical treatments, and the biological production method inherently maintains product stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the cost-effective production of high yields of glucosamine and N-acetylglucosamine, overcoming the limitations of traditional methods by providing a sustainable and efficient fermentation process that meets market demands while avoiding shellfish-derived allergens.
Implementation Method 1
a method to produce glucosamine or N-acetylglucosamine by fermentation
Implementation Method 2
genetic modification that increases the activity of glucosamine-6-phosphate acetyltransferase
Data Source
AI summary
A biosynthetic method for producing glucosamine and N-acetylglucosamine is disclosed. Such a method includes the fermentation of a genetically modified microorganism to produce glucosamine and/or N-acetylglucosamine. Also disclosed are genetically modified microorganisms that are useful for producing glucosamine and N-acetylglucosamine. In addition, methods of recovering N-acetylglucosamine that has been produced by a fermentation process, including methods that result in N-acetylglucosamine of high purity, are described. Also disclosed is a method to produce glucosamine from N-acetylglucosamine.